rendering of a globe and news stories

PPD in the News

PharmaVOICE (February 2021)

Fulfilling a great promise

Evidera’s Jonca Bull comments on how cell and gene therapies hold such great promise, despite being among the most complex clinical trials in terms of design and execution.

PharmaVoice logo
European Pharmaceutical Contractor (February 2021)

Embracing a functional service partnership model for rapidly growing biotechs

Jan-Maarten Kroodsma and Timothy King discuss how a tailored functional service partnership model can provide expertise and flexibility for biotechnology companies.

European Pharmaceutical Contractor
Contract Pharma (January 2021)

The slow – but desperately needed – evolution of oncology clinical development designs

Jürgen Hummel outlines how adaptive designs at the early stages of development can not only accelerate timelines and reduce costs, but also can help focus development on the most promising agents at the right doses in the right indications for the right patients.

contract pharma logo
Contract Pharma (January 2021)

Selecting the right outsourcing model for emerging biotech

Timothy King and Elisha Talley-Roithner discuss how smaller and emerging biotech companies are able to take advantage of a range of flexible outsourcing models.

contract pharma logo
BioPharm International (December 2020)

Can cell and gene therapies achieve their full potential?

PPD’s Stephen Gacheru comments on the cell and gene therapy methods he sees the industry using in the future.

biopharm logo
Pharmaceutical Outsourcing (December 2020)

A brief guide on designing a comprehensive cell and gene therapy bioanalytical strategy

PPD’s Panteli Theocharous, Janine Micheli and Catherine Vrentas outline how the application of cell and gene therapy offers the promise of significant long-term health benefits to people suffering from a wide range of diseases.

pharmaceutical outsourcing logo
Pharmaceutical Technology (December 2020)

Complying with lab data integrity practices during COVID-19

PPD’s John Maier discusses how accelerated startup and overall timelines of COVID-19 trials have presented a significant challenge to ensuring compliance with lab data integrity regulations.

pharmaceutical technology logo
Applied Clinical Trials (December 2020)

Facilitating adoptive cell therapy clinical trials

PPD’s Panteli Theocharous and Fiona Thistlethwaite of The Christie NHS Foundation Trust discuss both the site and CRO role to improve the patient journey through the clinical development process, as well as the patient and product process pathway from initial referral through to follow-up.

applied clinical trials logo
Genetic Engineering & Biotechnology News (December 2020)

Viral safety testing: Keeping the fly out of the ointment

PPD’s Panteli Theocharous and Patrick Bennett comment on the evolving nature of gene therapies.